Young Ho Koh

Dr. Young Ho Koh

Korea national institute of health
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2014 in Autophagy
Verified
Journal Article
Closed access
SCSun-Jung Cho
Sun-Jung Cho
SYSang-Moon Yun
Sang-Moon Yun
CJChulman Jo
Chulman Jo
DLDae-Hoon Lee
Dae-Hoon Lee
KCKi Ju Choi
Ki Ju Choi
YKYoung Ho Koh
Young Ho Koh
Autophagy is one of the main mechanisms in the pathophysiology of neurodegenerative disease. The accumulation of autophagic vacuoles (AVs) in affected neurons is responsible for amyloid-β (Aβ) production. Previously, we reported that SUMO1 (small ubiquitin-like modifier 1) increases Aβ levels. In this study, we explored the mechanisms underlying this. We investigated whether AV formation is necessary for Aβ production by SUMO1. Overexpression of SUMO1 increased autophagic activation, inducing the formation of LC3-II-positive AVs in neuroglioma H4 cells. Consistently, autophagic activation was decreased by the depletion of SUMO1 with small hairpin RNA (shRNA) in H4 cells. The SUMO1-mediated increase in Aβ was reduced by the autophagy inhibitors (3-methyladenine or wortmannin) or genetic inhibitors (siRNA targeting ATG5, ATG7, ATG12, or HIF1A), respectively. Accumulation of SUMO1, ATG12, and LC3 was seen in amyloid precursor protein transgenic mice. Our results suggest that SUMO1 accelerates the accumulation of AVs and promotes Aβ production, which is a key mechanism for understanding the AV-mediated pathophysiology of Alzheimer disease.

18 December 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SCSun-Jung Cho
Sun-Jung Cho
MPMoon Ho Park
Moon Ho Park
CHChangsu Han
Changsu Han
KYKeejung Yoon
Keejung Yoon
YKYoung Ho Koh
Young Ho Koh
Alzheimer’s disease (AD) is a common disorder of progressive cognitive decline among elderly subjects. Angiogenesis-related factors including vascular endothelial growth factor (VEGF) might be involved in the pathogenesis of AD. Soluble form of the VEGF receptor is likely to be an intrinsic negative counterpart of VEGF. We measured the plasma levels of VEGF and its two soluble receptors (sVEGFR1 and sVEGFR2) in 120 control subjects, 75 patients with mild cognitive impairment, and 76 patients with AD using ELISA. Plasma levels of VEGF in patients with AD were higher than those in healthy control subjects. However, plasma levels of sVEGFR1 and sVEGFR2 were lower in patients with AD than in healthy control subjects. Levels of VEGFR2 mRNA were significantly decreased in human umbilical vein endothelial cells after amyloid-beta treatment. Further, protein levels of VEGFR2 were also decreased in the brains of AD model mice. In addition, we show that the expression of sVEGFR2 and VEGFR2 was also decreased by the transfection with the Notch intracellular domain. These results indicate that the alterations of VEGF and its two receptors levels might be associated with those at risk for Alzheimer’s disease.

12 May 2011 in BMC Neurology
Verified
Journal Article
Open access
PDF file
SKSam-Moon Kim
Sam-Moon Kim
JSJuhee Song
Juhee Song
SKSeungwoo Kim
Seungwoo Kim
CHChangsu Han
Changsu Han
MPMoon Ho Park
Moon Ho Park
YKYoung-Youl Kim
Young-Youl Kim
Multiple pathogenic factors may contribute to the pathophysiology of Alzheimer's disease (AD). Peripheral blood markers have been used to assess biochemical changes associated with AD and mild cognitive impairment (MCI) and involved in their pathophysiology.

2 September 2010 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
BJBong Geom Jang
Bong Geom Jang
SYSang-Moon Yun
Sang-Moon Yun
KAKyungsook Ahn
Kyungsook Ahn
JSJu Hee Song
Ju Hee Song
SJSangmee A. Jo
Sangmee A. Jo
YKYoung Ho Koh
Young Ho Koh
Carbonic anhydrase (CA) plays a critical role in pH regulation, long-term synaptic transformation, and is associated with mental retardation, Alzheimer's disease (AD), and Down syndrome. There is accumulating evidence that CAII is increased in AD bra

2 December 2009 in BMC Public Health
Verified
Journal Article
Open access
PDF file
JSJi A Seo
Ji A Seo
BKByoung Gwon Kim
Byoung Gwon Kim
HCHyunjoo Cho
Hyunjoo Cho
HKHye Sook Kim
Hye Sook Kim
JPJuri Park
Juri Park
Nan Hee KimNan Hee Kim
Nan Hee Kim
Background: In Korea, the cutoff values of waist circumference (WC) for the identification of metabolic syndrome (MetS) were suggested to be 90 cm for men and 85 cm for women based on the analysis mainly in middle-aged adults. As aging is associated with increased fat, especially abdominal visceral fat, the cutoff value of WC may differ according to age. In addition, the usefulness of visceral abdominal fat area (VFA) to predict MetS in the elderly has not been studied yet. We aimed to suggest WC and VFA criteria and to compare the predictability of WC and VFA to identify people at risk for MetS.Methods: A total of 689 elderly subjects aged ≥63 years (308 men, 381 women) were chosen in this cross-sectional study from an ongoing, prospective, population-based study, the Ansan Geriatric (AGE) cohort study. VFA was measured by single slice abdominal computed tomography scanning. The metabolic risk factors except WC (plasma glucose, blood pressure, serum triglycerides and HDL cholesterol levels) were defined using modified NCEP-ATP III criteria. We estimated the accuracy of VFA and WC for identifying at least two of these factors by receiver operating characteristic (ROC) curve analysis.Results: Two hundred three of 308 men and 280 of 381 women had ≥2 metabolic risk factors. The area under the ROC curve (AUC) value for VFA to predict the presence of ≥2 metabolic risk factors was not significantly different from that for WC (men, 0.735 and 0.750; women, 0.715 and 0.682; AUC values for VFA and WC, respectively). The optimal cutoff points for VFA and WC for predicting the presence of ≥2 metabolic risk factors were 92.6 cm2and 86.5 cm for men and 88.9 cm2and 86.5 cm for women.Conclusion: WC had comparable power with VFA to identify elderly people who are at risk for MetS. Elderly Korean men and women had very similar cutoff points for both VFA and WC measurements for estimating the risk of MetS. Age-specific cutoff point for WC might be considered to identify subjects at risk for MetS.

26 November 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SCSun-Jung Cho
Sun-Jung Cho
SYSang-Moon Yun
Sang-Moon Yun
CJChulman Jo
Chulman Jo
JJJihyun Jeong
Jihyun Jeong
MPMoon Ho Park
Moon Ho Park
YKYoung Ho Koh
Young Ho Koh
Notch signaling is an evolutionarily conserved pathway that regulates cell-cell interactions through binding of Notch family receptors to their cognate ligands. Notch signaling has an essential role in vascular development and angiogenesis. Recent studies have reported that Notch may be implicated in Alzheimer’s disease (AD) pathophysiology. We measured the levels of soluble Notch1 (sNotch1) in the plasma samples from 72 dementia patients (average age 75.1 y), 89 subjects with amnestic mild cognitive impairment (MCI) (average age 73.72 y), and 150 cognitively normal controls (average age 72.34 y). Plasma levels of sNotch1 were 25.27% lower in dementia patients as compared to healthy control subjects. However, the level of Notch1 protein was significantly increased in human brain microvascular endothelial cells (HBMECs) after amyloid-beta treatment. Also, Notch1 mRNA level was significantly increased in HBMECs and iPSC-derived neuronal cells from AD patient compared to normal control. These results indicate that altered expression of Notch1 might be associated with the risk of Alzheimer’s disease.